INCY
Incyte Corporation
Latest News for INCY
In a report released yesterday, Derek Archila from Wells Fargo maintained a Hold rating on Incyte, with a price target of $101.00. The company’s sh......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lipocine (LPCN), Viridian Therapeutics (VRDN) and Incyte (INCY). ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Incyte (INCY), Sanofi (SNYNF) and Johnson & Johnso......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Incyte (INCY) and Veradigm (MDRX) with bullish senti......
Incyte ($INCY) announced an update on their ongoing clinical study. The Phase 1 trial “A Phase 1, Open-Label, Multicenter Study of INCA036978 in Pa......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $95.89 | 0% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |